Genoway 

€2.49
6
-€0.03-1.19% Thursday 15:35

Statistics

Day High
2.49
Day Low
2.46
52W High
3.5
52W Low
2.1
Volume
3,934
Avg. Volume
-
Mkt Cap
23.61M
P/E Ratio
15.06
Dividend Yield
-
Dividend
-

Earnings

17OctExpected
Q3 2019
Q1 2020
Q2 2020
Q1 2021
Q2 2021
Q2 2022
Q3 2022
-0.18
-0.11
-0.03
0.04
Expected EPS
0
Actual EPS
0.02

Financials

8.3%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
44.12MRevenue
3.66MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALGEN.PA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is involved in gene editing, a direct competitor in the genetic engineering space where Genoway also operates.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine focuses on genome editing using CRISPR technology, competing in the same biotechnological advancements as Genoway.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is another key player in the CRISPR/Cas9 technology sector, making it a direct competitor to Genoway's gene editing services.
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Sangamo Therapeutics specializes in genomic medicine, including gene therapy and gene editing, areas where Genoway is also active.
Beam Therapeutics
BEAM
Mkt Cap2.53B
Beam Therapeutics works on precision genetic medicines using base editing, a novel form of gene editing competing with Genoway's offerings.
Adaptive Biotechnologies
ADPT
Mkt Cap2.64B
Adaptive Biotechnologies focuses on the genetic understanding of the immune system, which can be seen as competing in the broader genetic research market.
Twist Bioscience
TWST
Mkt Cap1.99B
Twist Bioscience operates in the synthetic biology space, producing synthetic DNA that is crucial for genetic research and development, overlapping with Genoway's market.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences provides advanced sequencing solutions, essential for genetic research and directly competitive with Genoway's services.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides sequencing and array-based solutions for genetic analysis, which is foundational to the genetic research and development industry, competing with Genoway's offerings.

About

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.
Show more...
CEO
Dr. Alexandre Fraichard
Country
FR
ISIN
FR0004053510

Listings

0 Comments

Share your thoughts

FAQ

What is Genoway stock price today?
The current price of ALGEN.PA is €2.49 EUR — it has decreased by -1.19% in the past 24 hours. Watch Genoway stock price performance more closely on the chart.
What is Genoway stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genoway stocks are traded under the ticker ALGEN.PA.
Is Genoway stock price growing?
ALGEN.PA stock has risen by +2.47% compared to the previous week, the month change is a +6.41% rise, over the last year Genoway has showed a -6.39% decrease.
What is Genoway market cap?
Today Genoway has the market capitalization of 23.61M
What were Genoway earnings last quarter?
ALGEN.PA earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0 EUR resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Genoway revenue for the last year?
Genoway revenue for the last year amounts to 44.12M EUR.
What is Genoway net income for the last year?
ALGEN.PA net income for the last year is 3.66M EUR.
In which sector is Genoway located?
Genoway operates in the Health Care sector.
When did Genoway complete a stock split?
Genoway has not had any recent stock splits.
Where is Genoway headquartered?
Genoway is headquartered in Lyon, FR.